Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Summary
To assess the effectiveness of interventions including health monitoring and regular return follow-up reminders for patients with a high Composite Immune Risk Score.
Official title: Using the Composite Immune Risk Score to Assess and Modulate the Patient's Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation, a Prospective, Multicenter, Randomized Controlled Study.
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
INTERVENTIONAL
Enrollment
456
Start Date
2024-02-29
Completion Date
2028-04-01
Last Updated
2024-08-13
Healthy Volunteers
No
Conditions
Interventions
Health monitoring and regular return follow-up reminders
Health monitoring \& reminders for blood tests and follow-up visits until 1 year post-transplant
Locations (1)
Institute of Hematology & Blood Diseases Hospital
Tianjin, Tianjin Municipality, China